On September 9, 2020 Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, reported that it will be featured as a presenting company at the 22nd Annual Global Investment Conference sponsored by H.C Wainwright (Press release, Arcadia Biosciences, SEP 9, 2020, https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-22nd-annual-global-investment-conference-september-14-16-2020-301126240.html [SID1234564890]). The conference is being held virtually on September 14-16, 2020.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Matthew Plavan, Arcadia’s president and CEO will present a business overview at 2:00 p.m. EDT on Wednesday, September 16, 2020 and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hccwevents.com.
The presentation will be webcast live here, and a replay will be available in the Investors section of the company’s website.